BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20156940)

  • 1. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure.
    Harjola VP; Follath F; Nieminen MS; Brutsaert D; Dickstein K; Drexler H; Hochadel M; Komajda M; Lopez-Sendon JL; Ponikowski P; Tavazzi L
    Eur J Heart Fail; 2010 Mar; 12(3):239-48. PubMed ID: 20156940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.
    Nieminen MS; Brutsaert D; Dickstein K; Drexler H; Follath F; Harjola VP; Hochadel M; Komajda M; Lassus J; Lopez-Sendon JL; Ponikowski P; Tavazzi L; ;
    Eur Heart J; 2006 Nov; 27(22):2725-36. PubMed ID: 17000631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I; Rubonivich S; Azaz-Livshits T
    Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure.
    Siirilä-Waris K; Lassus J; Melin J; Peuhkurinen K; Nieminen MS; Harjola VP;
    Eur Heart J; 2006 Dec; 27(24):3011-7. PubMed ID: 17127708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central venous pressure at emergency room presentation predicts cardiac rehospitalization in patients with decompensated heart failure.
    Uthoff H; Thalhammer C; Potocki M; Reichlin T; Noveanu M; Aschwanden M; Staub D; Arenja N; Socrates T; Twerenbold R; Mutschmann-Sanchez S; Heinisch C; Jaeger KA; Mebazaa A; Mueller C
    Eur J Heart Fail; 2010 May; 12(5):469-76. PubMed ID: 20223880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rationale and indications for angiotensin receptor blockers in heart failure.
    Bybee KA; Das S; O'Keefe JH
    Heart Fail Clin; 2006 Jan; 2(1):81-8. PubMed ID: 17386879
    [No Abstract]   [Full Text] [Related]  

  • 9. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II.
    Komajda M; Hanon O; Hochadel M; Lopez-Sendon JL; Follath F; Ponikowski P; Harjola VP; Drexler H; Dickstein K; Tavazzi L; Nieminen M
    Eur Heart J; 2009 Feb; 30(4):478-86. PubMed ID: 19106198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
    Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short to long term mortality of patients hospitalised with heart failure in the Czech Republic--a report from the EuroHeart Failure Survey.
    Rosolova H; Cech J; Simon J; Spinar J; Jandova R; Widimský sen J; Holubec L; Topolcan O
    Eur J Heart Fail; 2005 Aug; 7(5):780-3. PubMed ID: 16051521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of long-term (4-year) mortality in elderly and young patients with acute heart failure.
    Barsheshet A; Shotan A; Cohen E; Garty M; Goldenberg I; Sandach A; Behar S; Zimlichman E; Lewis BS; Gottlieb S;
    Eur J Heart Fail; 2010 Aug; 12(8):833-40. PubMed ID: 20494926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heart failure: critical patients].
    Fabbri G; Gorini M; Maggioni AP; Oliva F;
    G Ital Cardiol (Rome); 2007 Sep; 8(9):568-73. PubMed ID: 17972426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short-term prognosis and treatment of patients hospitalized for acute heart failure in a regional hospital without a cardiocentre].
    Zeman K; Pohludková L; Spinar J; Jarkovský J; Littnerová S; Dušek L; Miklík R; Felšöci M; Pařenica J
    Vnitr Lek; 2012 Apr; 58(4):273-9. PubMed ID: 22559800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure--a population study.
    Hudson M; Rahme E; Behlouli H; Sheppard R; Pilote L
    Eur J Heart Fail; 2007; 9(6-7):602-9. PubMed ID: 17383932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of valsartan for the treatment of heart-failure patients not receiving ACE inhibitors: a budget impact analysis.
    Smith DG; Cerulli A; Frech FH
    Clin Ther; 2005 Jun; 27(6):951-9. PubMed ID: 16117995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.
    Yancy CW; Lopatin M; Stevenson LW; De Marco T; Fonarow GC;
    J Am Coll Cardiol; 2006 Jan; 47(1):76-84. PubMed ID: 16386668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey.
    Rivero-Ayerza M; Scholte Op Reimer W; Lenzen M; Theuns DA; Jordaens L; Komajda M; Follath F; Swedberg K; Cleland JG
    Eur Heart J; 2008 Jul; 29(13):1618-24. PubMed ID: 18515809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.